Prestige Wealth Management Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.97K | Buy |
+9
| New | +$1.97K | ﹤0.01% | 736 |
|
|
2024
Q3 | – | Sell |
-5
| Closed | -$1.65K | – | 1048 |
|
|
2024
Q2 | $1.65K | Hold |
5
| – | – | ﹤0.01% | 755 |
|
|
2024
Q1 | $1.98K | Hold |
5
| – | – | ﹤0.01% | 744 |
|
|
2023
Q4 | $1.76K | Hold |
5
| – | – | ﹤0.01% | 766 |
|
|
2023
Q3 | $1.88K | Hold |
5
| – | – | ﹤0.01% | 750 |
|
|
2023
Q2 | $1.91K | Hold |
5
| – | – | ﹤0.01% | 764 |
|
|
2023
Q1 | $1.73K | Sell |
5
-6
| -55% | -$2.08K | ﹤0.01% | 771 |
|
|
2022
Q4 | $2.59K | Sell |
11
-4
| -27% | -$941 | ﹤0.01% | 777 |
|
|
2022
Q3 | $4K | Buy |
15
+5
| +50% | +$1.33K | ﹤0.01% | 631 |
|
|
2022
Q2 | $3K | Sell |
10
-8
| -44% | -$2.4K | ﹤0.01% | 715 |
|
|
2022
Q1 | $8K | Hold |
18
| – | – | ﹤0.01% | 521 |
|
|
2021
Q4 | $8K | Sell |
18
-3
| -14% | -$1.33K | ﹤0.01% | 538 |
|
|
2021
Q3 | $9K | Hold |
21
| – | – | ﹤0.01% | 515 |
|
|
2021
Q2 | $8K | Buy |
21
+3
| +17% | +$1.14K | ﹤0.01% | 534 |
|
|
2021
Q1 | $5K | Buy |
18
+1
| +6% | +$278 | ﹤0.01% | 639 |
|
|
2020
Q4 | $5K | Hold |
17
| – | – | ﹤0.01% | 602 |
|
|
2020
Q3 | $5K | Hold |
17
| – | – | ﹤0.01% | 552 |
|
|
2020
Q2 | $4K | Sell |
17
-5
| -23% | -$1.18K | ﹤0.01% | 578 |
|
|
2020
Q1 | $3K | Buy |
+22
| New | +$3K | ﹤0.01% | 602 |
|
|
2019
Q1 | – | Sell |
-20
| Closed | -$2K | – | 1151 |
|
|
2018
Q4 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 894 |
|